Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bornhäuser

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Blood Cancer Journal|June 14, 2014
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemiaA Ehninger, M Kramer, C Röllig, et al.
Clinical Transplantation|June 8, 2001
Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantationA Jenke, U Renner, M Richte, et al.
Bone Marrow Transplantation|April 15, 2003
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantationB Wassmann, U Scheuring, C Thiede, et al.
Bone Marrow Transplantation|June 23, 2018
Net reclassification improvement with serial biomarkers and bed-sided spirometry to early predict the need of organ support during the early post-transplantation in-hospital stay in allogeneic HCT recipientsS D Braun, M Kuhn, S Bergmann, et al.
Transplantation|May 15, 2001
Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantationU Platzbecker, D Bandt, C Thiede, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|February 6, 2010
[Perspectives of clinical stem cell therapy in the treatment of musculoskeletal diseases in Germany]P Kasten, P Bernstein, A Biewener, et al.
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
Bone Marrow Transplantation|August 5, 2000
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulinM Bornhäuser, C Thiede, U Schuler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patientsM Bornhäuser, C Thiede, U Platzbecker, et al.
British Journal of Haematology|November 28, 2001
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysisM Bornhäuser, M Kiehl, W Siegert, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Blood Cancer Journal|June 14, 2014
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemiaA Ehninger, M Kramer, C Röllig, et al.
Clinical Transplantation|June 8, 2001
Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantationA Jenke, U Renner, M Richte, et al.
Bone Marrow Transplantation|April 15, 2003
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantationB Wassmann, U Scheuring, C Thiede, et al.
Bone Marrow Transplantation|June 23, 2018
Net reclassification improvement with serial biomarkers and bed-sided spirometry to early predict the need of organ support during the early post-transplantation in-hospital stay in allogeneic HCT recipientsS D Braun, M Kuhn, S Bergmann, et al.
Transplantation|May 15, 2001
Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantationU Platzbecker, D Bandt, C Thiede, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|February 6, 2010
[Perspectives of clinical stem cell therapy in the treatment of musculoskeletal diseases in Germany]P Kasten, P Bernstein, A Biewener, et al.
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
Bone Marrow Transplantation|August 5, 2000
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulinM Bornhäuser, C Thiede, U Schuler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patientsM Bornhäuser, C Thiede, U Platzbecker, et al.
British Journal of Haematology|November 28, 2001
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysisM Bornhäuser, M Kiehl, W Siegert, et al.
Pageof 11